Histology independent therapies (HITs)
This leaflet is about histology independent therapies (HITs). HITs are a type of cancer treatment used to treat cancers that have a certain gene change.
This leaflet is about histology independent therapies (HITs). HITs are a type of cancer treatment used to treat cancers that have a certain gene change.
About this leaflet
There are 2 HIT drugs currently available. These drugs are larotrectinib (Vitrakvi®) and entrectinib (Rozlytrek®). They can be used to treat people with a cancer that has a gene change called NTRK gene fusion.
This leaflet has been developed in partnership with NHS England, the charities Cancer Research UK, Sarcoma UK and Teenage Cancer Trust, and a working group of people affected by cancer. It is supported by the Accelerated Access Collaborative at NHS England.
Visit our online information about histology independent therapies (HITs).
We want everyone affected by cancer to feel our information is written for them. To do this we use plain English and we try to make it accessible and relevant to the widest range of people. Read more about how we produce our information.
How we can help
Our specialist money advisers can give you free and confidential advice and help you to find out what benefits and financial support you might be entitled to.